Vimian Group AB Logo

Vimian Group AB

Global animal health company in pharma, medtech, diagnostics, and vet services.

VIMIAN | ST

Overview

Corporate Details

ISIN(s):
SE0015961982 (+2 more)
LEI:
549300OQ8R5TCAP0BS18
Country:
Sweden
Address:
Riddargatan 19, 114 57 Stockholm

Description

Vimian Group is a global animal health company that applies science and technology to improve animal well-being. The company operates across four main segments: Specialty Pharma, MedTech, Veterinary Services, and Diagnostics. Through its portfolio of businesses, Vimian develops, manufactures, and distributes a wide range of products and services, including pharmaceuticals, medical devices, diagnostic tools, and specialized veterinary care. Its growth strategy combines in-house research and development with the acquisition of innovative companies to expand its offerings for veterinary professionals, clinics, and laboratories.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-09 08:00
Vimian överväger emission av seniort icke-säkerställt obligationslån
Swedish 105.5 KB
2025-05-09 08:00
Vimian contemplates issuance of a senior unsecured bond
English 105.0 KB
2025-05-07 10:15 Swedish 10.4 KB
2025-05-02 11:06 Swedish 10.7 KB
2025-04-29 16:20
Kommuniké från årsstämman i Vimian Group AB (publ) den 29 april 2025
Swedish 103.6 KB
2025-04-29 16:20
Press release from the Annual General Meeting in Vimian Group AB (publ) on 29 A…
English 102.5 KB
2025-04-29 07:45 Swedish 4.6 MB
2025-04-29 07:45 English 1.6 MB
2025-04-28 09:32 Swedish 8.5 KB
2025-04-24 08:46 Swedish 8.7 KB
2025-04-04 16:30
Vimian Group AB (publ) terminates liquidity guarantee agreement
English 95.2 KB
2025-04-01 13:47 Swedish 14.4 KB
2025-03-28 08:30
Notice of Annual General Meeting in Vimian Group AB (publ)
English 261.3 KB
2025-03-28 07:30
Trading in Vimian Group AB (publ)’s ordinary shares on Nasdaq Stockholm commenc…
English 104.7 KB

Automate Your Workflow. Get a real-time feed of all Vimian Group AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Vimian Group AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Vimian Group AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-02-14 Sven Johan Magnus Göte Kjellberg Other Sell 425,000 19,167,500.00 SEK
2024-12-23 Sven Johan Magnus Göte Kjellberg Other Sell 25,000 1,026,000.00 SEK

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.